Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19

Author:

Otani Naruhito1,Shima Masayuki1ORCID,Ueda Takashi2ORCID,Nakajima Kazuhiko2,Takesue Yoshio2,Yamamoto Takuma3,Okuno Toshiomi4

Affiliation:

1. Department of Public Health, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan

2. Department of Infection Control and Prevention, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan

3. Department of Legal Medicine, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan

4. Department of Microbiology, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan

Abstract

Rubella is an infectious disease caused by the rubella virus. Congenital rubella syndrome is a risk for all newborns if pregnant women are infected with rubella, raising an important public health issue. Rubella is a vaccine-preventable disease, and routine immunization has been conducted in Japan. The timing of the vaccine approval did not differ from that in the United States. In 2004, endemic rubella was eliminated in the United States. However, recent rubella outbreaks have occurred in Japan. This may be related to differences in the introduction of routine rubella immunization. In Japan, routine rubella immunization was initially introduced only for junior high school girls, and the rate of susceptibility is high among males who have not received rubella vaccination, causing an outbreak. Therefore, in Japan, measures have been taken to decrease the number of susceptible males in the vaccination-free generation. The coronavirus pandemic has also affected the epidemiology of rubella as well as other infectious diseases.

Funder

Japan Society for the Promotion of Science

Hyogo Medical University Grant for Research Promotion

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference51 articles.

1. World Health Organization (2020). Rubella Vaccines: WHO Position Paper. Wkly. Epidemiol. Rec., 95, 301–324. Available online: https://www.who.int/publications/i/item/WHO-WER9527.

2. Plotkin, S.A., Orenstein, W.A., Offit, P.A., and Edwards, K.M. (2018). Plotkin’s Vaccines, Elsevier. [7th ed.].

3. World Health Organization (2011). Rubella VACCINES: WHO position Paper. Wkly. Epidemiol. Rec., 86, 301–316. Available online: https://www.who.int/publications/i/item/WER8629.

4. Rubella vaccination in the United States: A ten-year review;Preblud;Epidemiol. Rev.,1980

5. National Institute of Infectious Diseases (2003). Rubella. IASR, 24, 53–54. Available online: https://idsc.niid.go.jp/iasr/24/277/tpc277.html.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3